Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied Dna Scns (NQ: APDN )

1.196 -0.034 (-2.74%)
Streaming Delayed Price Updated: 11:02 AM EDT, May 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40,855
Open 1.240
Bid (Size) 1.150 (5)
Ask (Size) 1.230 (82)
Prev. Close 1.230
Today's Range 1.180 - 1.330
52wk Range 1.082 - 8.050
Shares Outstanding 8,234,320
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: Applied DNA Sciences Q2 Earnings
Applied DNA Sciences (NASDAQ:APDN) reported its Q2 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
From Applied DNA Sciences, Inc.
Via Business Wire

Performance

YTD
-72.93%
-72.93%
1 Month
-34.45%
-34.45%
3 Month
-55.19%
-55.19%
6 Month
-74.97%
-74.97%
1 Year
-79.19%
-79.19%

More News

Read More
Earnings Outlook For Applied DNA Sciences
Via Benzinga
Applied DNA Schedules Fiscal 2022 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 12, 2022
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Raises $4.2M Via Registered Direct Offering
Via Benzinga
Applied DNA Sciences To Raise $4.2M Via Registered Direct Offering
Via Benzinga
Applied DNA Awarded NYC-Based ‘Return-to-Office’
From Applied DNA Sciences, Inc
Via Business Wire
Applied DNA to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
From Applied DNA Sciences, Inc.
Via Business Wire
Earnings Scheduled For February 10, 2022
Via Benzinga
Applied DNA Executes LOI with Spindle Biotech for Research Collaboration on Simplified High Yield mRNA Production System
From Applied DNA Sciences, Inc. and Spindle Biotech Inc.
Via Business Wire
InvestorNewsBreaks — Applied DNA Sciences Inc. (NASDAQ: APDN) Closes on $4.2M Registered Direct Offering
Via Investor Brand Network
Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
From Applied DNA Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering
From Applied DNA Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Applied DNA and EvviVax Announce Publication of Positive Preclinical Data for LinearDNA™ Platform Approach to Cancer Immunotherapy
From Applied DNA Sciences, Inc.
Via Business Wire
Looking Into Applied DNA Sciences's Return On Capital Employed
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
78 Biggest Movers From Friday
Via Benzinga
41 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
52 Weeks High And Low Article
Via Benzinga
Recap: Applied DNA Sciences Q1 Earnings
Via Benzinga
Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Schedules Fiscal 2022 First Quarter Financial Results Conference Call and Webcast for Thursday, February 10, 2022
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA to Deploy Linea™ 1.0 COVID-19 Assay for Rapid Detection of New Omicron Subvariant BA.2
From Applied DNA Sciences, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.